Historical record - last NADAC effective date: 3/23/2022
Product Information
MUCINEX SINUS-MAX PRESSURE-CGH is a brand product labeled by RB Health (US) LLC, priced at $0.7369 per EA under NDC 63824069308. Its NADAC has been published 74 times since Feb 3, 2021.
The High Outlier badge above means this manufacturer's average price in the ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
MUCINEX SINUS-MAX PRESSURE-CGH
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
RB Health (US) LLCNDC
63824069308
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
3/23/2022
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/1/2017
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX SINUS-MAX PRESSURE-CGH has been published 74 times since Feb 3, 2021, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7369 per EA |
|---|---|
| All-time high | $0.7673 (Oct 13, 2021) |
| All-time low | $0.7132 (Feb 3, 2021) |
| Median price | $0.7354 |
| Average price | $0.7368 |
| Largest weekly change | -5.7% (Feb 23, 2022) |
| Weeks tracked | 74 |
| Tracking since | Feb 3, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+0.4%
All
+3.3%
Last surveyed Jun 29, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MUCINEX SINUS-MAX PRESSURE-CGH?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX SINUS-MAX PRESSURE-CGH, manufactured by RB Health (US) LLC, is $0.7369 per EA (NDC 63824069308), effective Jun 29, 2022.
How has the price of MUCINEX SINUS-MAX PRESSURE-CGH changed over time?
Over the history we have for it, the NADAC for MUCINEX SINUS-MAX PRESSURE-CGH has risen 3.3%. It has been tracked across 74 weekly CMS publications since Feb 3, 2021.
What are the highest and lowest recorded NADAC prices for MUCINEX SINUS-MAX PRESSURE-CGH?
Since Feb 3, 2021, the NADAC for MUCINEX SINUS-MAX PRESSURE-CGH has ranged from a low of $0.7132 (Feb 3, 2021) to a high of $0.7673 (Oct 13, 2021), with a median of $0.7354 per EA.
Are there cheaper alternatives to MUCINEX SINUS-MAX PRESSURE-CGH?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MUCINEX SINUS-MAX PRESSURE-CGH in a comparable dosage form, but none are currently priced below it.
Who manufactures MUCINEX SINUS-MAX PRESSURE-CGH?
MUCINEX SINUS-MAX PRESSURE-CGH (NDC 63824069308) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.